Zobrazeno 1 - 10
of 22
pro vyhledávání: '"J W, Singleton"'
Autor:
J W, Singleton, S B, Hanauer, G L, Gitnick, M A, Peppercorn, M G, Robinson, L D, Wruble, E L, Krawitt
Publikováno v:
Gastroenterology. 104(5)
Mesalamine is released from sulfasalazine in the colon and benefits colonic Crohn's disease. The mesalamine used in this study releases the drug throughout the small bowel and colon. Therefore, this study was designed to detect benefit for Crohn's di
Autor:
J. W. Singleton
Publikováno v:
Current Opinion in Gastroenterology. 4:455-461
Publikováno v:
Journal of Clinical Investigation. 45:637-644
Publikováno v:
Gastroenterology. 70(3)
Needing a single index of degree of illness in Crohn's disease, the National Cooperative Crohn's Disease Study group collected data prospectively from 187 visits of 112 patients with Crohn's disease of the small bowel, colon, or both. Information on
Publikováno v:
Gastroenterology. 77(4 Pt 2)
On-study barium radiographs of 535 patients in the National Cooperative Crohn's Disease Study have been analyzed for the pattern of distribution of bowel disease and the individual features that characterized bowel involvement. On-study and off-study
Publikováno v:
Gastroenterology. 87(4)
A variety of bacterial pathogens including Campylobacter, Yersinia, Listeria, Brucella, and Mycobacteria have been suggested as potential etiologic agents for Crohn's disease. To assess the role of these organisms we studied responses to eight antige
Publikováno v:
Gastroenterology. 77(4 Pt 2)
The design and execution of the National Cooperative Crohn's Disease Study are described in this paper. The Study incorporated several noteworthy features developed to meet specific demands of the disease and its therapy. A standard clinical grading
Autor:
J W, Singleton
Publikováno v:
Zeitschrift fur Gastroenterologie. Verhandlungsband. 19
Publikováno v:
Gastroenterology. 77(4 Pt 2)
The effect of the combination of sulfasalazine and prednisone has been compared with that of prednisone and placebo in 89 actively symptomatic patients with Crohn's disease in a double-blind, randomized, multicenter controlled trial. The combination